Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Rheumatoid Arthritis

Free Subscription Articles published in Arthritis Res Ther Retrieve available abstracts of 208 articles: HTML format

Single Articles

May 2026
1. CHEN J, Yin Z, Dang W, Jian C, et al
   Lipid metabolism dysregulation in rheumatoid arthritis: from multi-omics discovery to adjunctive therapy with conjugated linoleic acid.
   Arthritis Res Ther. 2026 May 19. doi: 10.1186/s13075-026-03831.
   PubMed     Abstract available
   
   
   
2. WANG X, Su J, Feng S, Qu J, et al
   Targeting mitochondrial fission-autophagy axis in rheumatoid arthritis: leflunomide promote apoptosis of fibroblast-like synoviocytes.
   Arthritis Res Ther. 2026 May 16. doi: 10.1186/s13075-026-03828.
   PubMed     Abstract available
   
   
   
3. LIU J, Xie W, Cao Y, Zhang L, et al
   IRE1/p?JNK/NRF2 axis-mediated GPX4 upregulation underlies ferroptosis resistance in rheumatoid arthritis fibroblast-like synoviocytes.
   Arthritis Res Ther. 2026 May 9. doi: 10.1186/s13075-026-03827.
   PubMed     Abstract available
   
   
   
4. FLOUDA S, Grigoriou M, Sentis G, Grivas A, et al
   Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunity.
   Arthritis Res Ther. 2026 May 6. doi: 10.1186/s13075-026-03767.
   PubMed     Abstract available
   
   
   April 2026
5. MOLINA-COLLADA J, Bellon JM, Blanco-Caceres B, Coronel L, et al
   Ultrasound evaluation of muscle quality in rheumatoid arthritis: a reliability study of the Spanish Ultrasound Muscle Assessment in Rheumatoid Arthritis (SpUMAR) score.
   Arthritis Res Ther. 2026 Apr 24. doi: 10.1186/s13075-026-03815.
   PubMed    
   
   
   
6. HASHMI SW, Andonian BJ, Thompson MM, Bennett WC, et al
   Immunoglobulin G and plasma glycome in early rheumatoid arthritis differ from matched controls and link less fat-free mass to an accelerated aging phenotype: an exploratory study.
   Arthritis Res Ther. 2026 Apr 21. doi: 10.1186/s13075-026-03818.
   PubMed    
   
   
   
7. SERVIN AE, Lillie M, Jin R, Coates LC, et al
   Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA((R)) in the United Kingdom using data from a national register.
   Arthritis Res Ther. 2026 Apr 21. doi: 10.1186/s13075-026-03807.
   PubMed    
   
   
   
8. CHAE HY, Yi K, Lim SG, Park JY, et al
   LIN28A?let-7b axis drives the aggressive and proinflammatory phenotype of rheumatoid arthritis fibroblast-like synoviocytes.
   Arthritis Res Ther. 2026 Apr 13. doi: 10.1186/s13075-026-03809.
   PubMed    
   
   
   
9. JIANG Y, Su L, Zhao X, Jia X, et al
   Inflammation-related composite indices and their association with osteoporosis and fragility fractures in rheumatoid arthritis.
   Arthritis Res Ther. 2026 Apr 9. doi: 10.1186/s13075-026-03797.
   PubMed    
   
   
   March 2026
10. CHEN DP, Hsu FP, Lin WT, Wang WT, et al
    The association between methotrexate metabolism-related gene polymorphisms and therapeutic efficacy and toxicity in patients with rheumatoid arthritis.
    Arthritis Res Ther. 2026 Mar 25. doi: 10.1186/s13075-026-03795.
    PubMed    
    
    
    
11. ZHAO H, Shu J, Yu F, Lu C, et al
    LncRNA MIAT inhibits osteoblast differentiation and function in rheumatoid arthritis via let-7i-5p/ CKIP-1 axis.
    Arthritis Res Ther. 2026 Mar 20. doi: 10.1186/s13075-026-03798.
    PubMed    
    
    
    
12. ZHU D, Sun F, Zheng X, Cai W, et al
    Characteristics of CLA(+)Tregs in rheumatoid arthritis and their potential as biomarkers of treatment response.
    Arthritis Res Ther. 2026 Mar 19. doi: 10.1186/s13075-026-03791.
    PubMed    
    
    
    
13. CHEN Z, Zhao W, Yang D, Xie R, et al
    Sleep quality, duration, and multi-trajectories as predictors of rheumatoid arthritis: evidence from the english longitudinal study of ageing.
    Arthritis Res Ther. 2026 Mar 4. doi: 10.1186/s13075-026-03784.
    PubMed    
    
    
    February 2026
14. HUGLE T, Prillwitz H, Scholz G, Kyburz D, et al
    Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study.
    Arthritis Res Ther. 2026 Feb 27. doi: 10.1186/s13075-026-03766.
    PubMed    
    
    
    
15. YE L, Wang X, Yin J, Shi H, et al
    FASN-mediated metabolic reprogramming drives CD4(+) T cell hyperactivation in Sjogren's syndrome via fatty acid oxidation-dependent oxidative phosphorylation.
    Arthritis Res Ther. 2026;28:71.
    PubMed     Abstract available
    
    
    
16. LI J, Liu M, Peng Y, Wu R, et al
    Integrative multi-omics analysis reveals CXCL10-driven inflammation and TREM2 + macrophage-plasma cell survival niche as hallmarks of late-stage rheumatoid arthritis.
    Arthritis Res Ther. 2026 Feb 12. doi: 10.1186/s13075-026-03764.
    PubMed    
    
    
    
17. YU HC, Chen PC, Huang HB, Lu MC, et al
    Decreased expression of circ-CCDC134 mediated by TNF-alpha in patients with rheumatoid arthritis affects T cell function via targeting protein phosphatase 2A.
    Arthritis Res Ther. 2026 Feb 11. doi: 10.1186/s13075-026-03763.
    PubMed    
    
    
    
18. REGUILON L, Gomez JH, Carrillo-Tornel S, Saiz E, et al
    Subclinical atherosclerosis in rheumatoid arthritis is driven by MicroRNA polymorphisms and NETosis.
    Arthritis Res Ther. 2026 Feb 9. doi: 10.1186/s13075-025-03727.
    PubMed    
    
    
    
19. TORII M, Onishi A, Uozumi R, Hidaka Y, et al
    Effects of a personalized exercise program on physical function in older patients with rheumatoid arthritis at high risk of sarcopenia: results of a randomized controlled trial.
    Arthritis Res Ther. 2026 Feb 6. doi: 10.1186/s13075-026-03751.
    PubMed     Abstract available
    
    
    
20. WANG C, Zeng Y, Tan P, Yuan S, et al
    MSMP promotes an aberrant phenotype of fibroblast-like synoviocytes in rheumatoid arthritis by blocking autophagy via the RUNX1/GPR137B axis.
    Arthritis Res Ther. 2026 Feb 3. doi: 10.1186/s13075-026-03755.
    PubMed    
    
    
    January 2026
21. ZHENG H, Dai Y, Fang J, Lin S, et al
    Association between physical activity and all-cause mortality in rheumatoid arthritis: evidence from NHANES and UK Biobank cohort studies.
    Arthritis Res Ther. 2026 Jan 28. doi: 10.1186/s13075-026-03748.
    PubMed    
    
    
    
22. NAVARRETE M, Trivedi K, Klenke C, Zheng Z, et al
    The rheumatoid arthritis citrullinome is enriched in antigenic complement proteins.
    Arthritis Res Ther. 2026 Jan 28. doi: 10.1186/s13075-026-03750.
    PubMed     Abstract available
    
    
    
23. HUANG X, Lin X, Dai Z, Fang K, et al
    Global variation in the quality of care for rheumatoid arthritis and associated factors.
    Arthritis Res Ther. 2026 Jan 26. doi: 10.1186/s13075-026-03737.
    PubMed     Abstract available
    
    
    
24. MA B, Ma J, Dong X, Kan Y, et al
    Frailty as an indicator of adverse health outcomes in rheumatoid arthritis: a multicenter cross-sectional study.
    Arthritis Res Ther. 2026 Jan 26. doi: 10.1186/s13075-026-03753.
    PubMed    
    
    
    
25. LI S, Zhao Q, Cai X, He X, et al
    Rheumatoid arthritis and gout: a rare combination or overlooked coexistence?
    Arthritis Res Ther. 2026 Jan 26. doi: 10.1186/s13075-026-03746.
    PubMed     Abstract available
    
    
    
26. AGUILAR-COLL M, Molina-Molina M, Robles-Perez A, Roig-Kim M, et al
    Incidence and spectrum of primary respiratory disease throughout the course of rheumatoid arthritis: implications of structured repeated evaluation for detection and risk-factor analysis.
    Arthritis Res Ther. 2026 Jan 23. doi: 10.1186/s13075-026-03736.
    PubMed    
    
    
    
27. CHRISTOFOROU M, Chen J, Cooper D, Perretti M, et al
    Interleukin-6 blockade modulates monocyte recruitment to protect against diastolic dysfunction associated with inflammatory arthritis.
    Arthritis Res Ther. 2026;28:31.
    PubMed     Abstract available
    
    
    
28. MADRUGA DIAS J, Cerqueira M, Esperanca Almeida D, Canhao H, et al
    Microvascular imaging is superior to power doppler in synovitis vascular flow detection in rheumatoid arthritis using the OMERACT-EULAR scoring system.
    Arthritis Res Ther. 2026 Jan 10. doi: 10.1186/s13075-025-03706.
    PubMed     Abstract available
    
    
    
29. NOZAKI Y, Kishimoto K, Itami T, Tomita D, et al
    Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis.
    Arthritis Res Ther. 2026 Jan 2. doi: 10.1186/s13075-025-03722.
    PubMed     Abstract available
    
    
    December 2025
30. LUOZZO LD, Salvato M, Frizzera F, Khalid K, et al
    Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:227.
    PubMed     Abstract available
    
    
    
31. CAI D, Zhong C, Yang Z, Li J, et al
    Bone marrow mesenchymal stem cell-derived exosomes improve pyroptosis and mitochondrial integrity through miR-515-5p-mediated TLR4/NLRP3/GSDMD axis in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:226.
    PubMed     Abstract available
    
    
    
32. LIU H, Wu C, Li G, Peng X, et al
    IRF7 orchestrates proinflammatory macrophage polarization and joint destruction in rheumatoid arthritis.
    Arthritis Res Ther. 2025 Dec 8. doi: 10.1186/s13075-025-03708.
    PubMed    
    
    
    
33. ZHENG L, Li G, Hou Z
    Association between sleep disorders and rheumatoid arthritis in U.S. adults.
    Arthritis Res Ther. 2025 Dec 7. doi: 10.1186/s13075-025-03694.
    PubMed     Abstract available
    
    
    
34. LI J, Li S, Ka Y, Wang S, et al
    From autoimmune inflammation to malignancy: causal genetic evidence for the RA-squamous cell lung cancer axis.
    Arthritis Res Ther. 2025;28:3.
    PubMed     Abstract available
    
    
    November 2025
35. SHIN S, Kim MH, Oh CM, Cho D, et al
    Risk of gastrointestinal cancers in patients with primary Sjogren's syndrome in Korea: a nationwide retrospective cohort study.
    Arthritis Res Ther. 2025;28:12.
    PubMed     Abstract available
    
    
    
36. ITO H, Ishikawa H, Tsuji S, Nakayama M, et al
    Does perioperative discontinuation of anti-rheumatic drugs increase postoperative complications in orthopedic surgery for rheumatoid arthritis?
    Arthritis Res Ther. 2025;27:219.
    PubMed     Abstract available
    
    
    
37. FRITSCH K, Majnik J, Tomcik M, Gyebnar J, et al
    Screening for rheumatoid arthritis-associated interstitial lung disease using low-dose CT: an emerging approach - an observational prospective case-control study.
    Arthritis Res Ther. 2025;27:208.
    PubMed    
    
    
    
38. NOZAKI Y, Kishimoto K, Tomita D, Itami T, et al
    Stepwise dose reduction and discontinuation of bDMARD in rheumatoid arthritis: a prospective cohort study of flare-free population, flares, and predictive markers.
    Arthritis Res Ther. 2025;27:205.
    PubMed     Abstract available
    
    
    
39. PICCHIANTI DIAMANTI A, Paci V, Luchetti Gentiloni MM, Salemi S, et al
    Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS study.
    Arthritis Res Ther. 2025;27:203.
    PubMed     Abstract available
    
    
    October 2025
40. YOSHIDA Y, Hammer HB, Sexton J, Nordberg L, et al
    How to score the wrist joint by ultrasound: exploration of the most sensitive joint assessment during follow-up of early or established rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:200.
    PubMed    
    
    
    
41. RISKEDAL E, Jugessur A, Syversen SW, Hadley CL, et al
    A DNA methylation-based algorithm for diagnosing rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:192.
    PubMed     Abstract available
    
    
    
42. LIU Y, Wang XQ, Lu JH, Huang HW, et al
    Treg cells mitigate inflammatory responses and symptoms via beta2-AR/beta-Arr2/ERK signaling in an experimental rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:194.
    PubMed     Abstract available
    
    
    September 2025
43. NATALUCCI F, Triaille C, Sapart E, Dierckx S, et al
    Evolution from early to difficult-to-treat rheumatoid arthritis: incidence and risk factors in the ERA uclouvain Brussels cohort.
    Arthritis Res Ther. 2025;27:182.
    PubMed     Abstract available
    
    
    
44. ZHAO X, Sun X, Wu F, Huang K, et al
    Longitudinal patterns of obesity index changes and risk of incident rheumatoid arthritis: evidence from a population-based cohort.
    Arthritis Res Ther. 2025;27:186.
    PubMed     Abstract available
    
    
    
45. JIA Y, Li R, Huang L, Wu X, et al
    The Glycolysis-HIF-1alpha axis induces IL-1beta of macrophages in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:180.
    PubMed     Abstract available
    
    
    
46. FATIMA T, Zhang Y, Vasileiadis GK, Rawshani A, et al
    Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
    Arthritis Res Ther. 2025;27:177.
    PubMed    
    
    
    
47. BILBERG A, Bjersing J, Borjesson M, Sivertsson J, et al
    High-intensity exercise improves multidimensional fatigue and health-related quality of life in rheumatoid arthritis: a randomized controlled study.
    Arthritis Res Ther. 2025;27:176.
    PubMed     Abstract available
    
    
    
48. SHI Z, Ding Y, Dong X, Li G, et al
    The diagnostic value and clinical relevance of salivary gland ultrasound in patients with highly suspected Sjogren's Disease: a prospective monocentric study.
    Arthritis Res Ther. 2025;27:175.
    PubMed     Abstract available
    
    
    August 2025
49. MACHADO CRL, Choi E, Perumal NB, Benschop RJ, et al
    Regulation of fibroblast-like synoviocyte function by cadherin 6 in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:172.
    PubMed     Abstract available
    
    
    
50. LIU X, Fang F, Duan H, Wu C, et al
    KLF11 alleviates rheumatoid arthritis by regulating M1 macrophage polarization via downregulation of YAP1 expression.
    Arthritis Res Ther. 2025;27:171.
    PubMed     Abstract available
    
    
    
51. QIAO Z, Meng Q, Xiao B, Long Y, et al
    Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway.
    Arthritis Res Ther. 2025;27:167.
    PubMed     Abstract available
    
    
    
52. MUCIENTES A, Nunez GMM, Mena-Vazquez N, Lisbona-Montanez JM, et al
    Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study.
    Arthritis Res Ther. 2025;27:165.
    PubMed     Abstract available
    
    
    
53. TRIANTAFYLLIAS K, Bach M, Bogel S, Muthuraman M, et al
    Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjogren's: the SICARD cohort study.
    Arthritis Res Ther. 2025;27:164.
    PubMed     Abstract available
    
    
    July 2025
54. JOHANSSON L, Pratesi F, Errante F, Pacini L, et al
    Cytokines, chemokines and antibodies against histone-3/4 citrullinated peptides in rheumatoid arthritis patients with pulmonary fibrosis.
    Arthritis Res Ther. 2025;27:160.
    PubMed     Abstract available
    
    
    
55. ZHENG S, Zhou Z, Du G, Chen Q, et al
    The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:159.
    PubMed     Abstract available
    
    
    
56. FATIMA T, Zhang Y, Vasileiadis GK, Rawshani A, et al
    Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
    Arthritis Res Ther. 2025;27:156.
    PubMed     Abstract available
    
    
    
57. KACZMARCZYK B, Conde C, Gonzalez A
    Meta-analysis identifies the major impact of patient classification on the ACPA association with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Arthritis Res Ther. 2025;27:151.
    PubMed     Abstract available
    
    
    
58. RODRIGUEZ-MERLOS P, Cabrera-Alarcon JL, Ruiz-Esquide V, Chacur CA, et al
    Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold.
    Arthritis Res Ther. 2025;27:153.
    PubMed     Abstract available
    
    
    
59. BIRCK MG, Boivin J, Yan L, Carrier N, et al
    Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis.
    Arthritis Res Ther. 2025;27:150.
    PubMed     Abstract available
    
    
    
60. KALLIOLIAS GD, Basdra EK, Papavassiliou AG
    Killing arthritogenic fibroblast-like synoviocytes: an example using cytotoxic aptamers binding nucleolin.
    Arthritis Res Ther. 2025;27:148.
    PubMed     Abstract available
    
    
    
61. YOSHIDA T, Murotani Y, Murata K, Imai H, et al
    Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:143.
    PubMed     Abstract available
    
    
    
62. LIU Y, Xin Y, Wang W, Feng W, et al
    The association between metabolic syndrome severity and frailty risk in patients with rheumatoid arthritis: a cross-sectional study.
    Arthritis Res Ther. 2025;27:145.
    PubMed     Abstract available
    
    
    
63. WU T, Gu L, Shi B, Wu Y, et al
    nCD64 index as a new early predictive biomarker for macrophage activation syndrome in adult-onset still's disease.
    Arthritis Res Ther. 2025;27:144.
    PubMed     Abstract available
    
    
    
64. VEALE JD, Gorman A, Veale DJ, Fearon U, et al
    Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures.
    Arthritis Res Ther. 2025;27:147.
    PubMed     Abstract available
    
    
    
65. YUE G, Yan Y, Zeng X, Liu R, et al
    Association between rheumatoid arthritis and kidney stones: A cross-sectional study of NHANES 2007-2020.
    Arthritis Res Ther. 2025;27:141.
    PubMed     Abstract available
    
    
    
66. MAHER A, Hegazy MT, Algarf TM, Abdul-Aziz MA, et al
    Sicca manifestations and lymphoproliferation in hepatitis C virus: effects of direct acting antiviral therapy on dryness and B-cell activity compared to Sjogren's disease.
    Arthritis Res Ther. 2025;27:139.
    PubMed     Abstract available
    
    
    
67. BIERSTEKER R, Athanasiadou A, van der Meulen S, van Wesemael TJ, et al
    Insights into the detection of AMPA cross-reactivity: comparing cyclic peptide- to protein-based assays.
    Arthritis Res Ther. 2025;27:138.
    PubMed     Abstract available
    
    
    
68. WU R, Li B, Su R, Liu X, et al
    Serum tryptophan-kynurenine metabolites served as biomarkers of disease activity in rheumatoid arthritis and linked to immune imbalance.
    Arthritis Res Ther. 2025;27:136.
    PubMed     Abstract available
    
    
    
69. NOACK M, Miossec P
    IFNgamma production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:134.
    PubMed     Abstract available
    
    
    
70. BAEK IW, Kim HA, Park KS, Kim KJ, et al
    Targeting neutrophil-driven inflammation in adult-onset still's disease: molecular insights from gene expression profiles.
    Arthritis Res Ther. 2025;27:130.
    PubMed     Abstract available
    
    
    
71. MARTINEZ-RAMOS S, Rafael-Vidal C, Marty J, Malvar-Fernandez B, et al
    Semaphorin4B is elevated in rheumatoid arthritis and enhances the inflammatory phenotype of macrophages and fibroblast-like synoviocytes.
    Arthritis Res Ther. 2025;27:132.
    PubMed     Abstract available
    
    
    
72. KURAMOTO T, Sakuraba K, Kai K, Terada K, et al
    Risk factors affecting the vital prognosis in patients with rheumatoid arthritis after primary cervical spine surgery: a retrospective study.
    Arthritis Res Ther. 2025;27:131.
    PubMed     Abstract available
    
    
    June 2025
73. GOSSEC L, Patel J, Kadakia A, Fang S, et al
    Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study.
    Arthritis Res Ther. 2025;27:123.
    PubMed     Abstract available
    
    
    May 2025
74. WANG Z, Lan T, Jiao Y, Wang X, et al
    Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites.
    Arthritis Res Ther. 2025;27:111.
    PubMed     Abstract available
    
    
    
75. CURTIS JR, Conrad DM, Krueger WS, Gara AP, et al
    Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster.
    Arthritis Res Ther. 2025;27:108.
    PubMed     Abstract available
    
    
    
76. BAKER MC, Nagy D, Tamang S, Horvath-Puho E, et al
    Vagotomy and the incidence of rheumatoid arthritis and osteoarthritis: a Danish register-based study.
    Arthritis Res Ther. 2025;27:106.
    PubMed     Abstract available
    
    
    
77. VELA-CASASEMPERE P, Otero-Varela L, Gomez Sabater S, Cano Alameda R, et al
    Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naive patients with rheumatoid arthritis: Data from BIOBADASER III registry.
    Arthritis Res Ther. 2025;27:103.
    PubMed     Abstract available
    
    
    
78. VAN WESEMAEL TJ, Morton FR, Heutz JW, Maurits MP, et al
    Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:101.
    PubMed     Abstract available
    
    
    April 2025
79. KONG H, Qiao Y, Qi D, Zhao S, et al
    circ_0002970 promotes fibroblast-like synoviocytes invasion and the inflammatory response through Hippo/YAP signaling to induce CTGF/CCN1 expression in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:97.
    PubMed     Abstract available
    
    
    
80. HU C, Wang L, Huang J, Shang Y, et al
    Regional brain function study in patients with primary Sjogren's syndrome.
    Arthritis Res Ther. 2025;27:93.
    PubMed     Abstract available
    
    
    
81. O'BYRNE AM, Bolt JW, van Ansenwoude CMJ, van der Heijde M, et al
    Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients.
    Arthritis Res Ther. 2025;27:94.
    PubMed     Abstract available
    
    
    
82. HASHIMOTO T, Tsuboi K, Abe T, Yoshikawa T, et al
    Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study.
    Arthritis Res Ther. 2025;27:91.
    PubMed     Abstract available
    
    
    
83. MARIN J, Bourgoin P, Saverna N, Cartagena C, et al
    The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab.
    Arthritis Res Ther. 2025;27:86.
    PubMed     Abstract available
    
    
    
84. CHEN WS, Hsu HC, Lin TM, Chang YS, et al
    Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjogren syndrome patients on glucocorticoids: a nationwide population-based cohort study.
    Arthritis Res Ther. 2025;27:88.
    PubMed     Abstract available
    
    
    
85. OSTOR A, Feist E, Sidiropoulos P, Avouac J, et al
    Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study.
    Arthritis Res Ther. 2025;27:84.
    PubMed     Abstract available
    
    
    
86. WU W, Yang W, Deng B, Li H, et al
    Concomitant Sjogren's disease in patients with NMOSD: impacts on neurologic disease severity and recurrence.
    Arthritis Res Ther. 2025;27:78.
    PubMed     Abstract available
    
    
    
87. KHOROSHUN K, Bantel C, Hoffmann F, Jobski K, et al
    Methotrexate-related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance.
    Arthritis Res Ther. 2025;27:80.
    PubMed     Abstract available
    
    
    
88. ASAI S, Kojima T, Ishikawa H, Miyake N, et al
    Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.
    Arthritis Res Ther. 2025;27:82.
    PubMed     Abstract available
    
    
    
89. SHAO Y, Yang Y, Yang X, Xu Z, et al
    A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers.
    Arthritis Res Ther. 2025;27:75.
    PubMed     Abstract available
    
    
    March 2025
90. GOODWIN GL, Marin AC, Walker JV, Hobbs C, et al
    Using in vivo calcium imaging to examine joint neuron spontaneous activity and home cage analysis to monitor activity changes in mouse models of arthritis.
    Arthritis Res Ther. 2025;27:67.
    PubMed     Abstract available
    
    
    
91. FUJII T, Murata K, Kohjitani H, Onishi A, et al
    Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort.
    Arthritis Res Ther. 2025;27:65.
    PubMed     Abstract available
    
    
    
92. YANG X, Guo Q, Feng T, Lu Q, et al
    Correction: IL13Ralpha1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes.
    Arthritis Res Ther. 2025;27:64.
    PubMed    
    
    
    
93. WANG H, Yuan T, Wang J, Li D, et al
    Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis.
    Arthritis Res Ther. 2025;27:54.
    PubMed     Abstract available
    
    
    
94. ONISHI A, Tanaka M, Fujii T, Murata K, et al
    Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
    Arthritis Res Ther. 2025;27:52.
    PubMed     Abstract available
    
    
    February 2025
95. WU J, Feng R, Wang R, He J, et al
    Impact of disease duration on systemic clinical profile in Sjogren's syndrome.
    Arthritis Res Ther. 2025;27:39.
    PubMed     Abstract available
    
    
    
96. ASGARI N, Ghaemi EA, Tavasoli S, Aghaei M, et al
    Exploring the association between Mycobacterium avium subspecies paratuberculosis infection and rheumatoid arthritis: an immunological perspective.
    Arthritis Res Ther. 2025;27:36.
    PubMed     Abstract available
    
    
    
97. WANG X, Sun L, An Z, Li C, et al
    CXCL7 enhances RANKL-induced osteoclastogenesis via the activation of ERK/NFATc1 signaling pathway in inflammatory arthritis.
    Arthritis Res Ther. 2025;27:34.
    PubMed     Abstract available
    
    
    
98. NOMURA M, Sugihara T, Baba H, Hosoya T, et al
    Long-term outcome of a treat-to-target strategy in late-onset rheumatoid arthritis with chronic lung disease: 5-year results of a prospective observational study.
    Arthritis Res Ther. 2025;27:22.
    PubMed     Abstract available
    
    
    
99. ALTEN R, Behar C, Merckaert P, Afari E, et al
    Predicting abatacept retention using machine learning.
    Arthritis Res Ther. 2025;27:20.
    PubMed     Abstract available
    
    
    January 2025
100. TRIANTAFYLLIAS K, Alhaddad M, Schwarting A, Balaklytska V, et al
     Diagnostic performance of optical spectral transmission compared to magnetic resonance imaging in patients with inflammatory arthritis.
     Arthritis Res Ther. 2025;27:17.
     PubMed     Abstract available
     
     
     
101. SONG MK, Gu MF, Liu L, He LJ, et al
     GPIHBP1 increase accounts for rheumatic arthritis-related hypotriglyceridemia by facilitating lipids uptake of white adipose tissues.
     Arthritis Res Ther. 2025;27:16.
     PubMed     Abstract available
     
     
     
102. LIU H, Li Q, Chen Y, Dong M, et al
     Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK/STAT signaling pathway.
     Arthritis Res Ther. 2025;27:12.
     PubMed     Abstract available
     
     
     
103. FLORIS A, Angioni MM, Fadda M, Naitza MR, et al
     The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis.
     Arthritis Res Ther. 2025;27:9.
     PubMed     Abstract available
     
     
     
104. ZHOU Z, Wu S, Li Y, Shao P, et al
     Inhibition of macrophage polarization and pyroptosis in collagen-induced arthritis through MSC-exo and ginsenoside Rh2.
     Arthritis Res Ther. 2025;27:6.
     PubMed     Abstract available
     
     
     
105. LUCIANO N, Barone E, Brunetta E, D'Isanto A, et al
     Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender.
     Arthritis Res Ther. 2025;27:2.
     PubMed     Abstract available
     
     
     
106. WU JY, Zhang JY, Xia WQ, Kang YN, et al
     Predicting autoimmune thyroiditis in primary Sjogren's syndrome patients using a random forest classifier: a retrospective study.
     Arthritis Res Ther. 2025;27:1.
     PubMed     Abstract available
     
     
     December 2024
107. ARONSSON M, Bergman S, Lindqvist E, Andersson MLE, et al
     High leptin levels in blood are associated with chronic widespread pain in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:228.
     PubMed     Abstract available
     
     
     
108. AGNIHOTRI P, Saquib M, Joshi L, Malik S, et al
     Integrative metabolomic-proteomic analysis uncovers a new therapeutic approach in targeting rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:227.
     PubMed     Abstract available
     
     
     
109. WANG P, Wang D, Sui J, Liu S, et al
     The comprehensive relationship between combined anti-inflammatory and healthy diets and all-cause mortality in rheumatoid arthritis: results from NHANES 2003-2018.
     Arthritis Res Ther. 2024;26:226.
     PubMed     Abstract available
     
     
     
110. MAHARAJ N, Uppada DR, Reddy N, Reddy P, et al
     Comparing immunogenicity and safety following transition from reference rituximab to biosimilar rituximab (DRL_RI) in patients with rheumatoid arthritis: a randomized, double-blind, phase 3 study.
     Arthritis Res Ther. 2024;26:225.
     PubMed     Abstract available
     
     
     
111. ZHANG X, Liao Z, Chen Y, Lu H, et al
     A non-invasive model for diagnosis of primary Sjogren's disease based on salivary biomarkers, serum autoantibodies, and Schirmer's test.
     Arthritis Res Ther. 2024;26:217.
     PubMed     Abstract available
     
     
     
112. DIXIT T, Vaidya A, Ravindran S
     Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenies of rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:216.
     PubMed     Abstract available
     
     
     
113. DOS SANTOS GG, Jimenez-Andrade JM, Munoz-Islas E, Candanedo-Quiroz ME, et al
     Role of TLR4 activation and signaling in bone remodeling, and afferent sprouting in serum transfer arthritis.
     Arthritis Res Ther. 2024;26:212.
     PubMed     Abstract available
     
     
     
114. RAMIEN R, Rudi T, Alten R, Krause A, et al
     Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT.
     Arthritis Res Ther. 2024;26:209.
     PubMed     Abstract available
     
     
     
115. WEI J, Li J, Li T, Xu T, et al
     Genetically predicted metabolite mediates the causal relationship between immune cells and autoimmune diseases.
     Arthritis Res Ther. 2024;26:207.
     PubMed     Abstract available
     
     
     November 2024
116. D'ONOFRIO B, De Stefano L, Bozzalla Cassione E, Morandi V, et al
     Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat.
     Arthritis Res Ther. 2024;26:192.
     PubMed     Abstract available
     
     
     
117. KLIMAK M, Cimino A, Lenz KL, Springer LE, et al
     Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery.
     Arthritis Res Ther. 2024;26:190.
     PubMed     Abstract available
     
     
     
118. ZHU X, Long W, Zhang J, Jian C, et al
     Integrated multi-omics revealed that dysregulated lipid metabolism played an important role in RA patients with metabolic diseases.
     Arthritis Res Ther. 2024;26:188.
     PubMed     Abstract available
     
     
     October 2024
119. LI JB, Liu PC, Chen L, Wu R, et al
     Infiltrations of plasma cells in synovium predict inadequate response to Adalimumab in Rheumatoid Arthritis patients.
     Arthritis Res Ther. 2024;26:186.
     PubMed     Abstract available
     
     
     
120. BERGSTROM B, Sellden T, Bollmann M, Svensson MND, et al
     Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling.
     Arthritis Res Ther. 2024;26:178.
     PubMed     Abstract available
     
     
     
121. GEORGOPOULOS V, Smith S, McWilliams DF, Ferguson E, et al
     Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain.
     Arthritis Res Ther. 2024;26:175.
     PubMed     Abstract available
     
     
     September 2024
122. DING L, Park DH, Gao B, Wu L, et al
     Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in rheumatoid arthritis (RA).
     Arthritis Res Ther. 2024;26:173.
     PubMed     Abstract available
     
     
     
123. RUSCITTI P, Currado D, Rivellese F, Vomero M, et al
     Diminished expression of the ubiquitin-proteasome system in early treatment-naive patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort.
     Arthritis Res Ther. 2024;26:171.
     PubMed     Abstract available
     
     
     
124. LACKNER A, Dreo B, Hermann J, Zenz S, et al
     Patients' recollection about the onset of Sjogren's disease - a mixed methods study on the patients' perspective.
     Arthritis Res Ther. 2024;26:169.
     PubMed     Abstract available
     
     
     
125. TRIANTAFYLLIAS K, Altamimi KK, Schederecker F, Schwarting A, et al
     Increased predictive value of optical spectral transmission in early rheumatoid arthritis through use of patient-adjusted cut-off scores.
     Arthritis Res Ther. 2024;26:165.
     PubMed     Abstract available
     
     
     
126. CINCINELLI G, Maioli G, Posio C, Favalli EG, et al
     Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients.
     Arthritis Res Ther. 2024;26:161.
     PubMed     Abstract available
     
     
     
127. LENG X, Leszczynski P, Jeka S, Liu S, et al
     A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to met
     Arthritis Res Ther. 2024;26:157.
     PubMed     Abstract available
     
     
     August 2024
128. HETLAND ML, Strangfeld A, Bonfanti G, Soudis D, et al
     Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib.
     Arthritis Res Ther. 2024;26:153.
     PubMed     Abstract available
     
     
     
129. ZENG Y, Liu R, Li S, Wei J, et al
     Analysis of risk factors and development of a nomogram prediction model for renal tubular acidosis in primary Sjogren syndrome patients.
     Arthritis Res Ther. 2024;26:151.
     PubMed     Abstract available
     
     
     
130. NATALUCCI F, Triaille C, Van Mullem C, Sokolova T, et al
     Inclusion of fibrinoid necrosis increases the accuracy of synovial tissue assessment in predicting response to methotrexate: analysis of the UCLouvain Brussels ERA Cohort.
     Arthritis Res Ther. 2024;26:150.
     PubMed     Abstract available
     
     
     July 2024
131. VAN VOLLENHOVEN R, Strand V, Takeuchi T, Chavez N, et al
     Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial.
     Arthritis Res Ther. 2024;26:143.
     PubMed     Abstract available
     
     
     
132. OCHI S, Sonomoto K, Nakayamada S, Tanaka Y, et al
     Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry.
     Arthritis Res Ther. 2024;26:140.
     PubMed     Abstract available
     
     
     
133. KIEFER D, Soltani M, Damirchi P, Kiltz U, et al
     Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging.
     Arthritis Res Ther. 2024;26:138.
     PubMed     Abstract available
     
     
     
134. SONG YJ, Kim H, Cho SK, Kim HW, et al
     Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study.
     Arthritis Res Ther. 2024;26:137.
     PubMed     Abstract available
     
     
     
135. KALLIOLIAS GD, Papavassiliou AG
     Stabilizing the integrity of intestinal barrier to control arthritis.
     Arthritis Res Ther. 2024;26:135.
     PubMed     Abstract available
     
     
     
136. LUO J, Zhang J, Ju B, Wang Y, et al
     JAK inhibitors attenuate hyperactivation of nonswitched memory B cells in rheumatoid arthritis patients in remission.
     Arthritis Res Ther. 2024;26:134.
     PubMed     Abstract available
     
     
     
137. KOLLER-SMITH L, Mehdi A, March L, Tooth L, et al
     A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases.
     Arthritis Res Ther. 2024;26:133.
     PubMed     Abstract available
     
     
     
138. SU J, Hu W, Ding Y, Zhang P, et al
     Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study.
     Arthritis Res Ther. 2024;26:130.
     PubMed     Abstract available
     
     
     
139. HERNANDEZ-DIAZ M, Rodriguez-Gonzalez D, Heras-Recuero E, Gomez-Bernal F, et al
     The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:127.
     PubMed     Abstract available
     
     
     June 2024
140. LIAO KP, Rist P, Giles J, Santacroce L, et al
     Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial.
     Arthritis Res Ther. 2024;26:123.
     PubMed     Abstract available
     
     
     
141. CUBUK C, Lau R, Cutillas P, Rajeeve V, et al
     Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes.
     Arthritis Res Ther. 2024;26:120.
     PubMed     Abstract available
     
     
     
142. COHEN S, Beebe JS, Chindalore V, Guan S, et al
     A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with syst
     Arthritis Res Ther. 2024;26:117.
     PubMed     Abstract available
     
     
     May 2024
143. QIAN H, Deng C, Chen S, Zhang X, et al
     Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:103.
     PubMed     Abstract available
     
     
     
144. CHEN Z, Li X, Shi H, Huang Y, et al
     Causal relationship between rheumatoid arthritis and bronchiectasis: a bidirectional mendelian randomization study.
     Arthritis Res Ther. 2024;26:104.
     PubMed     Abstract available
     
     
     
145. CHEN X, Zhu L, Wu H
     The role of M1/M2 macrophage polarization in primary Sjogren's syndrome.
     Arthritis Res Ther. 2024;26:101.
     PubMed     Abstract available
     
     
     
146. LEHMANN J, Giaglis S, Kyburz D, Daoudlarian D, et al
     Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:97.
     PubMed     Abstract available
     
     
     
147. ITO Y, Ichikawa Y, Murashima S, Sakuma H, et al
     Rheumatoid arthritis disease activity significantly impacts on the severity of interstitial lung disease.
     Arthritis Res Ther. 2024;26:95.
     PubMed     Abstract available
     
     
     April 2024
148. YAMADA Z, Muraoka S, Kawazoe M, Hirose W, et al
     Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.
     Arthritis Res Ther. 2024;26:87.
     PubMed     Abstract available
     
     
     March 2024
149. POLLASTRO S, Musters A, Balzaretti G, Niewold I, et al
     Sensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:70.
     PubMed     Abstract available
     
     
     
150. CHRIST L, Kissling S, Finckh A, Fisher BA, et al
     Concomitant Sjogren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort.
     Arthritis Res Ther. 2024;26:68.
     PubMed     Abstract available
     
     
     
151. CHANG L, Zheng Z, Zhou Y, Liu K, et al
     B cell receptor repertoire analysis in primary Sjogren's syndrome salivary glands identifies repertoire features associated with clinical activity.
     Arthritis Res Ther. 2024;26:62.
     PubMed     Abstract available
     
     
     
152. LIU J, Idborg H, Korotkova M, Lend K, et al
     Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:61.
     PubMed     Abstract available
     
     
     February 2024
153. ZHANG J, Luo Y, Wu B, Huang X, et al
     Identifying functional dysregulation of NOD2 variant Q902K in patients with Yao syndrome.
     Arthritis Res Ther. 2024;26:58.
     PubMed     Abstract available
     
     
     
154. CALVO-GUTIERREZ J, Lopez-Medina C, Otero-Varela L, Escudero-Contreras A, et al
     Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.
     Arthritis Res Ther. 2024;26:57.
     PubMed     Abstract available
     
     
     
155. LI G, Fang Y, Xu N, Ding Y, et al
     Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes.
     Arthritis Res Ther. 2024;26:56.
     PubMed     Abstract available
     
     
     
156. O'NEIL LJ, Anaparti V, Winter T, Smolik I, et al
     Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for developing rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:51.
     PubMed     Abstract available
     
     
     
157. UKALOVIC D, Leeb BF, Rintelen B, Eichbauer-Sturm G, et al
     Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioReg.
     Arthritis Res Ther. 2024;26:44.
     PubMed     Abstract available
     
     
     
158. MALEKI-FISCHBACH M, Kastsianok L, Koslow M, Chan ED, et al
     Manifestations and management of Sjogren's disease.
     Arthritis Res Ther. 2024;26:43.
     PubMed     Abstract available
     
     
     
159. HOLLANDER NKD, Boeren AMP, van der Helm-van Mil AHM, van Steenbergen HW, et al
     Patients with obesity have more inflamed joints and higher CRP levels during the disease course in ACPA-positive RA but not in ACPA-negative RA.
     Arthritis Res Ther. 2024;26:42.
     PubMed     Abstract available
     
     
     January 2024
160. ZHANG J, Cai H, Sun W, Wu W, et al
     Endoplasmic reticulum aminopeptidase 2 regulates CD4(+) T cells pyroptosis in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:36.
     PubMed     Abstract available
     
     
     
161. XU M, Chen H, Tan T, Xie K, et al
     Exploring the causal association between rheumatoid arthritis and the risk of cervical cancer: a two-sample Mendelian randomization study.
     Arthritis Res Ther. 2024;26:35.
     PubMed     Abstract available
     
     
     
162. STRAUBE J, Bukhari S, Lerrer S, Winchester RJ, et al
     PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis.
     Arthritis Res Ther. 2024;26:32.
     PubMed     Abstract available
     
     
     
163. HONG J, Cheng H, Wang P, Wu Y, et al
     CXCL9 may serve as a potential biomarker for primary Sjogren's syndrome with extra-glandular manifestations.
     Arthritis Res Ther. 2024;26:26.
     PubMed     Abstract available
     
     
     
164. THORARINSDOTTIR K, McGrath S, Forslind K, Agelii ML, et al
     Cartilage destruction in early rheumatoid arthritis patients correlates with CD21(-/low) double-negative B cells.
     Arthritis Res Ther. 2024;26:23.
     PubMed     Abstract available
     
     
     
165. WU R, Wang D, Cheng L, Su R, et al
     Impaired immune tolerance mediated by reduced Tfr cells in rheumatoid arthritis linked to gut microbiota dysbiosis and altered metabolites.
     Arthritis Res Ther. 2024;26:21.
     PubMed     Abstract available
     
     
     
166. CHEN K, Tao H, Zhu P, Chu M, et al
     ADAM8 silencing suppresses the migration and invasion of fibroblast-like synoviocytes via FSCN1/MAPK cascade in osteoarthritis.
     Arthritis Res Ther. 2024;26:20.
     PubMed     Abstract available
     
     
     
167. AZUAGA AB, Cuervo A, Celis R, Frade-Sosa B, et al
     Synovial tissue features associated with poor prognosis in inflammatory arthritis.
     Arthritis Res Ther. 2024;26:18.
     PubMed     Abstract available
     
     
     
168. FUJII T, Murata K, Onizawa H, Onishi A, et al
     Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort.
     Arthritis Res Ther. 2024;26:16.
     PubMed     Abstract available
     
     
     
169. DI MUZIO C, Di Cola I, Shariat Panahi A, Ursini F, et al
     The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study.
     Arthritis Res Ther. 2024;26:14.
     PubMed     Abstract available
     
     
     
170. DUAN L, Li S, Li H, Shi Y, et al
     Causality between rheumatoid arthritis and the risk of cognitive impairment: a Mendelian randomization study.
     Arthritis Res Ther. 2024;26:5.
     PubMed     Abstract available
     
     
     
171. LEE HI, Ahn MJ, Yoo JK, Ahn SH, et al
     Exosome-mediated delivery of super-repressor IkappaBalpha alleviates inflammation and joint damages in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:2.
     PubMed     Abstract available
     
     
     
172. LUO Q, Zhu J, Wang S, Fu P, et al
     Decreased expression of NAT10 in peripheral blood mononuclear cells from new-onset ankylosing spondylitis and its clinical significance.
     Arthritis Res Ther. 2024;26:7.
     PubMed     Abstract available
     
     
     
173. IWASAKI T, Watanabe R, Ito H, Fujii T, et al
     Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:1.
     PubMed     Abstract available
     
     
     
174. THUDIUM CS, Frederiksen P, Karsdal MA, Bay-Jensen AC, et al
     Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab.
     Arthritis Res Ther. 2024;26:3.
     PubMed     Abstract available
     
     
     
175. KIM D, Heo Y, Kim M, Suminda GGD, et al
     Inhibitory effects of Acanthopanax sessiliflorus Harms extract on the etiology of rheumatoid arthritis in a collagen-induced arthritis mouse model.
     Arthritis Res Ther. 2024;26:11.
     PubMed     Abstract available
     
     
     December 2023
176. JIAN C, Wei L, Wu T, Li S, et al
     Comprehensive multi-omics analysis reveals the core role of glycerophospholipid metabolism in rheumatoid arthritis development.
     Arthritis Res Ther. 2023;25:246.
     PubMed     Abstract available
     
     
     
177. HUANG Y, Peng Y, Li H, Li C, et al
     Wilforine inhibits rheumatoid arthritis pathology through the Wnt11/beta-catenin signaling pathway axis.
     Arthritis Res Ther. 2023;25:243.
     PubMed     Abstract available
     
     
     
178. ZHANG X, He X, Zhang M, Wu T, et al
     Efficient delivery of the lncRNA LEF1-AS1 through the antibody LAIR-1 (CD305)-modified Zn-Adenine targets articular inflammation to enhance the treatment of rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:238.
     PubMed     Abstract available
     
     
     
179. LI J, Cui J, Wu L, Liu YB, et al
     Machine learning and molecular subtype analyses provide insights into PANoptosis-associated genes in rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:233.
     PubMed     Abstract available
     
     
     November 2023
180. RYDHOLM M, Sharma A, Jacobsson L, Turesson C, et al
     The relation between synovitis of individual finger joints and grip force over the first 5 years in early rheumatoid arthritis - a cohort study.
     Arthritis Res Ther. 2023;25:231.
     PubMed     Abstract available
     
     
     
181. SAINZ L, Riera P, Moya P, Bernal S, et al
     Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:226.
     PubMed     Abstract available
     
     
     
182. SOLOMON DH, Guan H, Johansson FD, Santacroce L, et al
     Assessing clusters of comorbidities in rheumatoid arthritis: a machine learning approach.
     Arthritis Res Ther. 2023;25:224.
     PubMed     Abstract available
     
     
     
183. KIELBASSA K, Van der Weele L, Voskuyl AE, de Vries N, et al
     Differential expression pattern of Bcl-2 family members in B and T cells in systemic lupus erythematosus and rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:225.
     PubMed     Abstract available
     
     
     
184. WARD MM, Madanchi N, Yazdanyar A, Shah NR, et al
     Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review.
     Arthritis Res Ther. 2023;25:222.
     PubMed     Abstract available
     
     
     
185. ZHOU D, Xie J, Wang J, Zong J, et al
     Establishment of a differential diagnosis method and an online prediction platform for AOSD and sepsis based on gradient boosting decision trees algorithm.
     Arthritis Res Ther. 2023;25:220.
     PubMed     Abstract available
     
     
     
186. YANG M, Su Y, Xu K, Xie J, et al
     Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study.
     Arthritis Res Ther. 2023;25:219.
     PubMed     Abstract available
     
     
     
187. GUO D, Pan H, Lu X, Chen Z, et al
     Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/beta-catenin pathway.
     Arthritis Res Ther. 2023;25:217.
     PubMed     Abstract available
     
     
     
188. TESSER J, Gul A, Olech E, Oelke K, et al
     Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials.
     Arthritis Res Ther. 2023;25:214.
     PubMed     Abstract available
     
     
     October 2023
189. BATHON JM, Centola M, Liu X, Jin Z, et al
     Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis.
     Arthritis Res Ther. 2023;25:213.
     PubMed     Abstract available
     
     
     
190. BRUCKNER S, Capria VM, Zeno B, Leblebicioglu B, et al
     The therapeutic effects of gingival mesenchymal stem cells and their exosomes in a chimeric model of rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:211.
     PubMed     Abstract available
     
     
     
191. RUYSSEN-WITRAND A, Guernec G, Dupont J, Lapuyade D, et al
     Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity.
     Arthritis Res Ther. 2023;25:207.
     PubMed     Abstract available
     
     
     
192. XUE L, Wang B, Li X, Zhu J, et al
     Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:201.
     PubMed     Abstract available
     
     
     
193. RODRIGUEZ-MARTINEZ L, Garcia-Moreno C, Perez-Pampin E, Gomara MJ, et al
     Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression.
     Arthritis Res Ther. 2023;25:192.
     PubMed     Abstract available
     
     
     
194. WANG Z, Zhang J, An F, Zhang J, et al
     The mechanism of dendritic cell-T cell crosstalk in rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:193.
     PubMed     Abstract available
     
     
     
195. WRIGHT M, Smed MK, Nelson JL, Olsen J, et al
     Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy.
     Arthritis Res Ther. 2023;25:191.
     PubMed     Abstract available
     
     
     
196. LI X, Wang Y, Chen Z, Ruan M, et al
     Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment.
     Arthritis Res Ther. 2023;25:188.
     PubMed     Abstract available
     
     
     
197. ZHANG F, Cheng T, Zhang SX
     Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:187.
     PubMed     Abstract available
     
     
     
198. HUANG Y, Xue Q, Chang J, Wang Y, et al
     M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.
     Arthritis Res Ther. 2023;25:189.
     PubMed     Abstract available
     
     
     September 2023
199. CIUREA A, Distler O, Kwok K, Jo H, et al
     Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start.
     Arthritis Res Ther. 2023;25:185.
     PubMed     Abstract available
     
     
     
200. BESSETTE L, Haraoui B, Rampakakis E, Dembowy J, et al
     Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept.
     Arthritis Res Ther. 2023;25:183.
     PubMed     Abstract available
     
     
     
201. RAMIREZ-PEREZ S, Vekariya R, Gautam S, Reyes-Perez IV, et al
     MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients.
     Arthritis Res Ther. 2023;25:180.
     PubMed     Abstract available
     
     
     
202. OKITA Y, Hirano T, Wang B, Nakashima Y, et al
     Automatic evaluation of atlantoaxial subluxation in rheumatoid arthritis by a deep learning model.
     Arthritis Res Ther. 2023;25:181.
     PubMed     Abstract available
     
     
     
203. AHMED S, Mahony CB, Torres A, Murillo-Saich J, et al
     Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:176.
     PubMed     Abstract available
     
     
     
204. LI M, Shi Y, Zhao J, Wang Q, et al
     Identification of potential susceptibility genes in patients with primary Sjogren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing.
     Arthritis Res Ther. 2023;25:175.
     PubMed     Abstract available
     
     
     
205. JUNG JY, Lee E, Kim JW, Suh CH, et al
     Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry.
     Arthritis Res Ther. 2023;25:174.
     PubMed     Abstract available
     
     
     
206. JIA Y, Yao P, Li J, Wei X, et al
     Causal associations of Sjogren's syndrome with cancers: a two-sample Mendelian randomization study.
     Arthritis Res Ther. 2023;25:171.
     PubMed     Abstract available
     
     
     
207. PAPPAS DA, O'Brien J, Guo L, Shan Y, et al
     Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry.
     Arthritis Res Ther. 2023;25:166.
     PubMed     Abstract available
     
     
     
208. SHAO Y, Zhang H, Shi Q, Wang Y, et al
     Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease.
     Arthritis Res Ther. 2023;25:159.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum